Europe Moves Nearer FDA- Style Drug Safety Agencies

3 March 1997

A call for the creation in the European Union of a US Food and DrugAdministration-type organization to monitor drug and food safety has come from the European Commission's President, Jacques Santer, in an address to the European Parliament.

While Mr Santer was mainly concerned with responding to criticism of the Commission over its handling of the bovine spongiform encephalopathy crisis in the agricultural sector, he said the BSE affair raised questions that went beyond agriculture and which affected society as a whole.

Referring to the need to "make difficult choices" in dealing with new developments in biotechnology, Mr Santer endorsed "a credible European health protection system" as a "necessary follow-on from the single market," and added that an independent agency on FDA lines should be considered.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight